Acquired
Novo Nordisk (Ozempic)
Ben Gilbert
Well, in February of 2021, after the clinical trial finishes on semaglutide for weight loss, so for Wegovy to hit the market in the U.S., the New York Times runs a story and just calls it a game changer. They say, for the first time, a drug has been shown to be so effective against obesity that patients may dodge many of its worst consequences, including diabetes.
0
💬
0
Comments
Log in to comment.
There are no comments yet.